Not Tagged
Not Tagged
['leukemia', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'leusm']
#ash22 #leusm tiong: mrd response (1 log reduction) 69% in mrd relapse cohort w median time to mrd neg 2 cycles, 77% in oligoblastic cohort w cr/cri after median 1 cycle. 2yr efs 55% in mrd relapse and 36% in oligoblastic, 2yr os 72% and 44% respectively. 2yr os 65% after allo. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)